Beyond M1/M2: The role of reactive oxygen species in liver fibrosis and immune modulation

Area of Science:

• Immunology
• Hepatology
• Oxidative Stress Research

Background:

• Liver fibrosis stems from chronic liver injury, marked by excessive extracellular matrix deposition.
• Reactive oxygen species (ROS) are increasingly recognized as crucial regulators of immune responses and fibrogenic pathways.
• Macrophages, traditionally M1/M2, display complex heterogeneity impacting liver fibrosis.

Purpose of the Study:

• To critically re-evaluate the dual role of ROS in liver fibrosis: as signaling mediators and oxidative stress inducers.
• To examine how ROS influence macrophage polarization, activation, and function in the fibrotic liver microenvironment.
• To explore the crosstalk between redox signaling and immune cells for antifibrotic strategies.

Main Methods:

• Literature review focusing on redox biology and immunology in liver fibrosis.
• Analysis of studies investigating ROS modulation of macrophage phenotypes (M1/M2 and beyond).
• Integration of findings on ROS-macrophage interactions and their impact on fibrogenesis and resolution.

Main Results:

• ROS exhibit dual functions, acting as both signaling molecules and inducers of oxidative stress in liver fibrosis.
• ROS significantly influence macrophage polarization and function, contributing to both disease progression and potential resolution.
• The complex interplay between ROS and macrophages is central to the fibrotic liver microenvironment's dynamics.

Conclusions:

• Targeting ROS and reprogramming immune cells offer novel therapeutic avenues for liver fibrosis.
• An integrative approach to redox-immunological interactions is essential for developing personalized antifibrotic treatments.
• Understanding ROS-mediated macrophage crosstalk provides a foundation for advanced antifibrotic interventions.